Page last updated: 2024-09-02

oxymatrine and tacrolimus

oxymatrine has been researched along with tacrolimus in 1 studies

Compound Research Comparison

Studies
(oxymatrine)
Trials
(oxymatrine)
Recent Studies (post-2010)
(oxymatrine)
Studies
(tacrolimus)
Trials
(tacrolimus)
Recent Studies (post-2010) (tacrolimus)
4121627017,7572,3196,661

Protein Interaction Comparison

ProteinTaxonomyoxymatrine (IC50)tacrolimus (IC50)
Bile salt export pumpHomo sapiens (human)7.18
Cytochrome P450 3A4Homo sapiens (human)0.58
Cytochrome P450 3A5Homo sapiens (human)0.385
Serine/threonine-protein kinase mTORHomo sapiens (human)0.0021
Peptidyl-prolyl cis-trans isomerase FKBP1AHomo sapiens (human)0.2547
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformHomo sapiens (human)0.0148
Splicing factor 3B subunit 3Homo sapiens (human)0.0123
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)3.3
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)3.7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MJ; Ding, PJ; Gao, CJ; He, XF; Tian, YX; Wang, DM; Yang, LL; Zhang, HM1

Other Studies

1 other study(ies) available for oxymatrine and tacrolimus

ArticleYear
Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt.
    Inflammation, 2018, Volume: 41, Issue:2

    Topics: Alkaloids; Cell Line; Chemokine CCL22; Down-Regulation; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interferon-gamma; Keratinocytes; MAP Kinase Signaling System; Quinolizines; RNA, Messenger; Skin Diseases; Suppressor of Cytokine Signaling 1 Protein; Tacrolimus

2018